Education
About Us
Working with TipRanks
Follow Us
PW Medtech Group Ltd. (DE:PWE)
FRANKFURT:PWE
PWE Stock Chart & Stats
€0.13
<€0.01(0.93%)
At close: 4:00 PM EST
€0.13
<€0.01(0.93%)
Day’s Range― - ―
52-Week Range€0.09 - €0.18
Previous CloseN/A
Volume0.00
Average Volume (3M)16.00
Market Cap
€213.03M
Enterprise Value-€18.31M
Total Cash (Recent Filing)€1.78B
Total Debt (Recent Filing)€20.28M
Price to Earnings (P/E)10.4
Beta-0.02
Next Earnings
Mar 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding1,473,589,100
10 Day Avg. Volume0
30 Day Avg. Volume16
Financial Highlights & Ratios
PEG Ratio-94.03
Price to Book (P/B)0.37
Price to Sales (P/S)1.89
P/FCF Ratio5.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth & MarginsSustained multi-year revenue expansion and high gross margins indicate durable product demand and pricing power in core medtech offerings. Consistent net income and improving margins support reinvestment capacity and operational resilience over the next several quarters.
Very Strong Balance SheetMinimal leverage and significant cash reserves give the company financial flexibility to fund R&D, expand capacity, pursue M&A or weather cyclical weakness. A strong equity base reduces refinancing risk and supports multi-quarter strategic initiatives.
Improving EBIT/EBITDA MarginsRising operating profitability reflects sustained cost discipline and scalable operations, which strengthens long-term cash generation potential. If maintained, higher operating margins improve free cash flow outlook and competitive positioning over coming quarters.
Bears Say
Operating Cash Flow CollapseA sudden cessation of operating cash inflows signals potential working-capital stress or one-off execution issues that impair cash conversion. Without recovery, the firm may need to draw reserves or curb investment, affecting growth initiatives and financial durability.
Rising Liabilities In 2024A growing liability base could raise fixed obligations or indicate increased short-term financing and working-capital needs. If sustained, higher liabilities can reduce financial flexibility and elevate refinancing or covenant risk across the next several reporting periods.
Negative EPS GrowthMaterial negative EPS growth points to volatility in profitability or share-level dilution that undermines earnings power. Persistent EPS contraction would constrain retained-earnings accumulation and reduce capacity to fund strategic spending without external financing.
PW Medtech Group Ltd. News
PWE FAQ
What was PW Medtech Group Ltd.’s price range in the past 12 months?
PW Medtech Group Ltd. lowest stock price was €0.09 and its highest was €0.18 in the past 12 months.
What is PW Medtech Group Ltd.’s market cap?
PW Medtech Group Ltd.’s market cap is €213.03M.
When is PW Medtech Group Ltd.’s upcoming earnings report date?
PW Medtech Group Ltd.’s upcoming earnings report date is Mar 27, 2026 which is in 37 days.
How were PW Medtech Group Ltd.’s earnings last quarter?
PW Medtech Group Ltd. released its earnings results on Aug 29, 2025. The company reported €0.005 earnings per share for the quarter, beating the consensus estimate of N/A by €0.005.
Is PW Medtech Group Ltd. overvalued?
According to Wall Street analysts PW Medtech Group Ltd.’s price is currently Overvalued.
Does PW Medtech Group Ltd. pay dividends?
PW Medtech Group Ltd. does not currently pay dividends.
What is PW Medtech Group Ltd.’s EPS estimate?
PW Medtech Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PW Medtech Group Ltd. have?
PW Medtech Group Ltd. has 1,473,589,100 shares outstanding.
What happened to PW Medtech Group Ltd.’s price movement after its last earnings report?
PW Medtech Group Ltd. reported an EPS of €0.005 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PW Medtech Group Ltd.?
Currently, no hedge funds are holding shares in DE:PWE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PW Medtech Group Ltd.
PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People's Republic of China. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens. It also provides property management services. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Technical Analysis
Shandong Weigao Group Medical Polymer Co
―
―
Modern Dental Group Limited
―
Shanghai Kindly Medical Instruments Co., Ltd. Class H
―
Angelalign Technology Inc.
―
Options Prices
Currently, No data available
---